Bio-Techne Corp. Stock
Bio-Techne Corp. Stock
Bio-Techne Corp. gained 2.040% today.
Bio-Techne Corp. is currently one of the favorites of our community with 10 Buy predictions and no Sell predictions.
However, we have a potential of -0.66% for Bio-Techne Corp. as the target price of 75 € is below the current price of 75.5 €.
Criterium "Worthwhile Investment for the next years" is seen as the biggest plus for Bio-Techne Corp. stock. Negative votes have not been in the majority for any criteria for this stock
Pros and Cons of Bio-Techne Corp. in the next few years
Pros
?
S********** s********
?
G***** c******* t* c**********
?
B****
Cons
?
M***** P*******
?
C******** o* t** e**********
?
W********* I********* f** t** n*** y****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Bio-Techne Corp. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Bio-Techne Corp. | 2.040% | 2.128% | 14.286% | -2.703% | 1.408% | - | - |
| Neogen Corp. | -3.510% | 0.885% | -12.308% | -25.974% | -37.705% | -70.955% | -57.692% |
| Bio-Rad Labs Inc. A | 3.230% | -2.536% | -18.894% | -24.223% | -13.590% | -49.260% | - |
| Merit Medical Systems | -1.360% | 4.255% | 10.526% | -4.545% | 8.088% | 38.679% | 47.650% |
Comments
Bio-Techne Co. (NASDAQ: TECH) had its "buy" rating re-affirmed by analysts at Benchmark Co.. They now have a $95.00 price target on the stock.
Show more
Ratings data for TECH provided by MarketBeat
Bio-Techne Co. (NASDAQ: TECH) had its price target raised by analysts at Robert W. Baird from $73.00 to $81.00. They now have an "outperform" rating on the stock.
Show more
Ratings data for TECH provided by MarketBeat
Bio-Techne Co. (NASDAQ: TECH) had its price target lowered by analysts at Stephens from $92.00 to $87.00. They now have an "overweight" rating on the stock.
Show more
Ratings data for TECH provided by MarketBeat